Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Surveillance of the progression and assessment of treatment endpoints for nonalcoholic steatohepatitis

Yi-wen Shi, Jian-Gao Fan

Clin Mol Hepatol. 2023;29(Suppl):S228-S243. Published online December 14, 2022

DOI: https://doi.org/10.3350/cmh.2022.0401

View: 3348 Download: 103

Original Article

Comparison of the clinical outcomes between antiviral-naïve patients treated with entecavir and lamivudine-resistant patients receiving adefovir add-on lamivudine combination treatment

Hong Joo Kim, Soo Kyung Park, Hyo Joon Yang, Yoon Suk Jung, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim, Kyu Yong Choi

Clin Mol Hepatol. 2016;22(3):350-358. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0019

View: 8895 Download: 138 Web of Science: 1 Crossref: 1

Efficacy and safety of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma as first-line therapy

Myung Jin Oh, Heon Ju Lee, Si Hyung Lee

Clin Mol Hepatol. 2013;19(3):288-299. Published online September 30, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.3.288

View: 8254 Download: 75 Crossref: 10

Impact of serum C-reactive protein level on the prognosis of patients with hepatocellular carcinoma undergoing TACE

Chung Hwan Jun, Ho Seok Ki, Ki Hoon Lee, Kang Jin Park, Seon Young Park, Sung Bum Cho, Chang Hwan Park, Young Eun Joo, Hyun Soo Kim, Sung Kyu Choi, Jong Sun Rew

Clin Mol Hepatol. 2013;19(1):70-77. Published online March 25, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.1.70

View: 8575 Download: 71 Web of Science: 25 Crossref: 18

7

The Korean Journal of Normal range of serum ALT level in patients with chronic hepatitis

Yeon Seok Seo

Clin Mol Hepatol. 2008;14(1):116-121. Published online March 20, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.1.116

View: 4132 Download: 18

1 |

Viewed By 5378	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5336	MAFLD: How is it different from NAFLD?
Viewed By 5226	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3904	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3871	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search